Fresenius Kabi

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Facing cancer together

Developing lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

Applying our strength,
experience, and passion

A lifesaving match

A lifesaving match

Facing cancer together

Facing cancer together

Developing lifesaving medicines
and advanced technologies

Answering the challenges
medical professionals face

Applying our strength,
experience, and passion

News

October 7, 2019

Fresenius Kabi Announces Availability of Fulvestrant Injection 250mg per 5mL prefilled syringe

Fresenius Kabi and AABB Celebrate 14th Annual Blood Collectors Week

Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP

Fresenius Kabi chooses Kenosha County for regional distribution center

Fresenius Kabi Introduces Levothyroxine Sodium Injection Solution

Fresenius Kabi Introduces Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation

Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications

Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations

Fresenius Kabi Introduces Adenosine Injection, USP Simplist® Prefilled Syringes in 6 mg per 2 mL and 12 mg per 4 mL Presentations

Fresenius Kabi Announces Availability of Fulvestrant Injection 250mg per 5mL prefilled syringe

Fresenius Kabi and AABB Celebrate 14th Annual Blood Collectors Week

Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP

Fresenius Kabi chooses Kenosha County for regional distribution center

Fresenius Kabi Introduces Levothyroxine Sodium Injection Solution

Fresenius Kabi Introduces Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

Fresenius Kabi Introduces Neostigmine Methylsulfate Injection, USP Simplist® Prefilled Syringe in 3 mg per 3 mL Presentation

Premier’s ProvideGx™ Subsidiary and Fresenius Kabi Collaborate to Address Drug Shortages for Five Critical Medications

Fresenius Kabi Introduces Glycopyrrolate Injection, USP Simplist® Prefilled Syringes in 0.2 mg per 1 mL and 0.4 mg per 2 mL Presentations

Fresenius Kabi Introduces Adenosine Injection, USP Simplist® Prefilled Syringes in 6 mg per 2 mL and 12 mg per 4 mL Presentations

EXPLORE PRODUCTS

We develop and deliver injectable drugs and delivery systems used to treat a broad spectrum of patients. Our portfolio also includes parenteral nutrition products and advanced medical devices for transfusion medicine, cell therapy lab processing and infusion.

CAREERS

As a part of Fresenius Kabi, you can enjoy an exciting career, a company culture based on a clear purpose and values, and the knowledge that your work makes a real difference. If you would like to learn more about us, we would love to hear from you.

EXPLORE PRODUCTS

CAREERS

October 19 - 22, 2019
|
USA, San Antonio, TX

AABB 2019 Annual Meeting

October 23 - 27, 2019
|
USA, Reno, NV

Wild West Veterinary Conference (WWVC) 2019

November 13 - 15, 2019
|
Australia, Brisbane Queensland

From Stem Cells to Gene to Therapies Conference

November 22, 2019
|
USA, Baltimore, MD

American Society for Apheresis (ASFA)

December 4 - 6, 2019
|
Netherlands, Amsterdam

Cell & Gene Therapy Europe 2019

October 19 - 22, 2019
|
USA, San Antonio, TX

AABB 2019 Annual Meeting

October 23 - 27, 2019
|
USA, Reno, NV

Wild West Veterinary Conference (WWVC) 2019

November 13 - 15, 2019
|
Australia, Brisbane Queensland

From Stem Cells to Gene to Therapies Conference

November 22, 2019
|
USA, Baltimore, MD

American Society for Apheresis (ASFA)

December 4 - 6, 2019
|
Netherlands, Amsterdam

Cell & Gene Therapy Europe 2019